Israel - English - Ministry of Health

novo nordisk ltd - repaglinide 0.5 mg - tablets - repaglinide - treatment of type ii diabetes.

Israel - English - Ministry of Health

novo nordisk ltd - repaglinide 1 mg - tablets - repaglinide - treatment of type ii diabetes .

Israel - English - Ministry of Health

novo nordisk ltd - repaglinide 2 mg - tablets - repaglinide - treatment of type ii diabetes.

Israel - English - Ministry of Health

teva pharmaceutical industries ltd, israel - repaglinide - tablets - repaglinide 0.5 mg - repaglinide - repaglinide - treatment of type ii diabetes.

Israel - English - Ministry of Health

teva pharmaceutical industries ltd, israel - repaglinide - tablets - repaglinide 1 mg - repaglinide - repaglinide - treatment of type ii diabetes.

Israel - English - Ministry of Health

teva pharmaceutical industries ltd, israel - repaglinide - tablets - repaglinide 2 mg - repaglinide - repaglinide - treatment of type ii diabetes.

Israel - English - Ministry of Health

astra zeneca israel ltd - exenatide 250 mcg/ml - solution for injection - exenatide - byetta is indicated as an adjunct to diet and exercise to improve glycimic control in adults with type 2 diabetes mellitus.byetta is indicated as adjunctive therapy to improve glycemic control in patients with type 2 diabetes mellitus who are taking metformin or a sulfonylurea , alone or in combination, but have not achieved adequate glycemic control.

Israel - English - Ministry of Health

astra zeneca israel ltd - exenatide 250 mcg/ml - solution for injection - exenatide - byetta is indicated as an adjunct to diet and exercise to improve glycimic control in adults with type 2 diabetes mellitus.byetta is indicated as adjunctive therapy to improve glycemic control in patients with type 2 diabetes mellitus who are taking metformin or a sulfonylurea , alone or in combination, but have not achieved adequate glycemic control.

Israel - English - Ministry of Health

astra zeneca israel ltd - exenatide 250 mcg/ml - solution for injection - exenatide - byetta is indicated as an adjunct to diet and exercise to improve glycimic control in adults with type 2 diabetes mellitus.byetta is indicated as adjunctive therapy to improve glycemic control in patients with type 2 diabetes mellitus who are taking metformin or a sulfonylurea , alone or in combination, but have not achieved adequate glycemic control.

Israel - English - Ministry of Health

astra zeneca israel ltd - exenatide 250 mcg/ml - solution for injection - exenatide - byetta is indicated as an adjunct to diet and exercise to improve glycimic control in adults with type 2 diabetes mellitus.byetta is indicated as adjunctive therapy to improve glycemic control in patients with type 2 diabetes mellitus who are taking metformin or a sulfonylurea , alone or in combination, but have not achieved adequate glycemic control.